Request for Covid-19 Impact Assessment of this Report

Medical Devices

COVID-19 Impact on Advanced Parenteral Drug Delivery Devices Market , Global Research Reports 2020-2021

  • BMR3866602
  • 97 Pages
  • May 2020
  • Medical Devices
Download Sample    Get Discount   
 
This report provides a complete quantitative data and qualitative analysis on the global market for Advanced Parenteral Drug Delivery Devices. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.

Prior to COVID-19, the global market for Advanced Parenteral Drug Delivery Devices was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Advanced Parenteral Drug Delivery Devices is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.

This report covers market size and forecasts of Advanced Parenteral Drug Delivery Devices, including the following market information:

Global Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)

Global Advanced Parenteral Drug Delivery Devices Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)

Global Advanced Parenteral Drug Delivery Devices Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)

Global Advanced Parenteral Drug Delivery Devices Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

Key market players

Major competitors identified in this market include Abbott Laboratories, Amgen, Pfizer, Roche, AstraZeneca, BD, Boston Scientific, Bristol-Myers Squibb, GSK, Novartis, etc.

Based on the Region:

Asia-Pacific (China, Japan, South Korea, India and ASEAN)

North America (US and Canada)

Europe (Germany, France, UK and Italy)

Rest of World (Latin America, Middle East & Africa)

Based on the Type:

Prefillable Syringes

IV Catheters

Vial Bag Infusion Systems

Hypodermic Syringes

Other Parenteral Delivery Devices

Based on the Application:

Hospitals

Clinics

ASCs

Others

1.1 Research Scope

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Advanced Parenteral Drug Delivery Devices Industry

1.7 COVID-19 Impact: Advanced Parenteral Drug Delivery Devices Market Trends

2 Global Advanced Parenteral Drug Delivery Devices Quarterly Market Size Analysis

2.1 Advanced Parenteral Drug Delivery Devices Business Impact Assessment - COVID-19

2.1.1 Global Advanced Parenteral Drug Delivery Devices Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Advanced Parenteral Drug Delivery Devices Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Advanced Parenteral Drug Delivery Devices Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Advanced Parenteral Drug Delivery Devices Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Advanced Parenteral Drug Delivery Devices Factory Price by Manufacturers

3.3 Location of Key Manufacturers Advanced Parenteral Drug Delivery Devices Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Advanced Parenteral Drug Delivery Devices Market

3.5 Key Manufacturers Advanced Parenteral Drug Delivery Devices Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Advanced Parenteral Drug Delivery Devices Segments, By Type

4.1 Introduction

1.4.1 Prefillable Syringes

1.4.2 IV Catheters

1.4.3 Vial Bag Infusion Systems

1.4.4 Hypodermic Syringes

1.4.5 Other Parenteral Delivery Devices

4.2 By Type, Global Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021

4.2.1 By Type, Global Advanced Parenteral Drug Delivery Devices Market Size by Type, 2020-2021

4.2.2 By Type, Global Advanced Parenteral Drug Delivery Devices Price, 2020-2021

5 Impact of Covid-19 on Advanced Parenteral Drug Delivery Devices Segments, By Application

5.1 Overview

5.5.1 Hospitals

5.5.2 Clinics

5.5.3 ASCs

5.5.4 Others

5.2 By Application, Global Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021

5.2.1 By Application, Global Advanced Parenteral Drug Delivery Devices Market Size by Application, 2019-2021

5.2.2 By Application, Global Advanced Parenteral Drug Delivery Devices Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 Abbott Laboratories

7.1.1 Abbott Laboratories Business Overview

7.1.2 Abbott Laboratories Advanced Parenteral Drug Delivery Devices Quarterly Production and Revenue, 2020

7.1.3 Abbott Laboratories Advanced Parenteral Drug Delivery Devices Product Introduction

7.1.4 Abbott Laboratories Response to COVID-19 and Related Developments

7.2 Amgen

7.2.1 Amgen Business Overview

7.2.2 Amgen Advanced Parenteral Drug Delivery Devices Quarterly Production and Revenue, 2020

7.2.3 Amgen Advanced Parenteral Drug Delivery Devices Product Introduction

7.2.4 Amgen Response to COVID-19 and Related Developments

7.3 Pfizer

7.3.1 Pfizer Business Overview

7.3.2 Pfizer Advanced Parenteral Drug Delivery Devices Quarterly Production and Revenue, 2020

7.3.3 Pfizer Advanced Parenteral Drug Delivery Devices Product Introduction

7.3.4 Pfizer Response to COVID-19 and Related Developments

7.4 Roche

7.4.1 Roche Business Overview

7.4.2 Roche Advanced Parenteral Drug Delivery Devices Quarterly Production and Revenue, 2020

7.4.3 Roche Advanced Parenteral Drug Delivery Devices Product Introduction

7.4.4 Roche Response to COVID-19 and Related Developments

7.5 AstraZeneca

7.5.1 AstraZeneca Business Overview

7.5.2 AstraZeneca Advanced Parenteral Drug Delivery Devices Quarterly Production and Revenue, 2020

7.5.3 AstraZeneca Advanced Parenteral Drug Delivery Devices Product Introduction

7.5.4 AstraZeneca Response to COVID-19 and Related Developments

7.6 BD

7.6.1 BD Business Overview

7.6.2 BD Advanced Parenteral Drug Delivery Devices Quarterly Production and Revenue, 2020

7.6.3 BD Advanced Parenteral Drug Delivery Devices Product Introduction

7.6.4 BD Response to COVID-19 and Related Developments

7.7 Boston Scientific

7.7.1 Boston Scientific Business Overview

7.7.2 Boston Scientific Advanced Parenteral Drug Delivery Devices Quarterly Production and Revenue, 2020

7.7.3 Boston Scientific Advanced Parenteral Drug Delivery Devices Product Introduction

7.7.4 Boston Scientific Response to COVID-19 and Related Developments

7.8 Bristol-Myers Squibb

7.8.1 Bristol-Myers Squibb Business Overview

7.8.2 Bristol-Myers Squibb Advanced Parenteral Drug Delivery Devices Quarterly Production and Revenue, 2020

7.8.3 Bristol-Myers Squibb Advanced Parenteral Drug Delivery Devices Product Introduction

7.8.4 Bristol-Myers Squibb Response to COVID-19 and Related Developments

7.9 GSK

7.9.1 GSK Business Overview

7.9.2 GSK Advanced Parenteral Drug Delivery Devices Quarterly Production and Revenue, 2020

7.9.3 GSK Advanced Parenteral Drug Delivery Devices Product Introduction

7.9.4 GSK Response to COVID-19 and Related Developments

7.10 Novartis

7.10.1 Novartis Business Overview

7.10.2 Novartis Advanced Parenteral Drug Delivery Devices Quarterly Production and Revenue, 2020

7.10.3 Novartis Advanced Parenteral Drug Delivery Devices Product Introduction

7.10.4 Novartis Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Advanced Parenteral Drug Delivery Devices Supply Chain Analysis

8.1.1 Advanced Parenteral Drug Delivery Devices Supply Chain Analysis

8.1.2 Covid-19 Impact on Advanced Parenteral Drug Delivery Devices Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Advanced Parenteral Drug Delivery Devices Distribution Channels

8.2.2 Covid-19 Impact on Advanced Parenteral Drug Delivery Devices Distribution Channels

8.2.3 Advanced Parenteral Drug Delivery Devices Distributors

8.3 Advanced Parenteral Drug Delivery Devices Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

List of Tables

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Advanced Parenteral Drug Delivery Devices Assessment

Table 9. COVID-19 Impact: Advanced Parenteral Drug Delivery Devices Market Trends

Table 10. COVID-19 Impact Global Advanced Parenteral Drug Delivery Devices Market Size

Table 11. Global Advanced Parenteral Drug Delivery Devices Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)

Table 12. Global Advanced Parenteral Drug Delivery Devices Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)

Table 13. Global Advanced Parenteral Drug Delivery Devices Quarterly Market Size, 2020 (US$ Million) & (K Units)

Table 14. Global Advanced Parenteral Drug Delivery Devices Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Advanced Parenteral Drug Delivery Devices Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)

Table 16. Global Advanced Parenteral Drug Delivery Devices Market Growth Drivers

Table 17. Global Advanced Parenteral Drug Delivery Devices Market Restraints

Table 18. Global Advanced Parenteral Drug Delivery Devices Market Opportunities

Table 19. Global Advanced Parenteral Drug Delivery Devices Market Challenges

Table 20. Key Manufacturers Advanced Parenteral Drug Delivery Devices Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Advanced Parenteral Drug Delivery Devices Market Size, 2019 (K Units) & (US$ Million)

Table 22. Advanced Parenteral Drug Delivery Devices Factory Price by Manufacturers 2020 (USD/Unit)

Table 23. Location of Key Manufacturers Advanced Parenteral Drug Delivery Devices Manufacturing Plants

Table 24. Key Manufacturers Advanced Parenteral Drug Delivery Devices Market Served

Table 25. Date of Key Manufacturers Enter into Advanced Parenteral Drug Delivery Devices Market

Table 26. Key Manufacturers Advanced Parenteral Drug Delivery Devices Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Advanced Parenteral Drug Delivery Devices Market Size by Type, 2020, (US$ Million)

Table 29. Global Advanced Parenteral Drug Delivery Devices Market Size by Type, 2020 (K Units)

Table 30. Global Advanced Parenteral Drug Delivery Devices Price: by Type, 2020-2021 (USD/Unit)

Table 31. Global Advanced Parenteral Drug Delivery Devices Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Advanced Parenteral Drug Delivery Devices Market Size by Application, 2020-2021 (K Units)

Table 33. Global Advanced Parenteral Drug Delivery Devices Price: by Application, 2020-2021 (USD/Unit)

Table 34. Global Advanced Parenteral Drug Delivery Devices Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Advanced Parenteral Drug Delivery Devices Market Size by Region, 2019-2021 (K Units)

Table 36. By Country, North America Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021 (K Units)

Table 38. US Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021 (US$ Million) & (K Units)

Table 39. Canada Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021 (US$ Million) & (K Units)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021 (K Units)

Table 43. Germany Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021 (US$ Million) & (K Units)

Table 44. France Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021 (US$ Million) & (K Units)

Table 45. UK Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021 (US$ Million) & (K Units)

Table 46. Italy Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021 (US$ Million) & (K Units)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021 (K Units)

Table 50. China Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021 (US$ Million) & (K Units)

Table 51. Japan Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021 (US$ Million) & (K Units)

Table 52. South Korea Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021 (US$ Million) & (K Units)

Table 53. India Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021 (US$ Million) & (K Units)

Table 54. ASEAN Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021 (US$ Million) & (K Units)

Table 55. Latin America Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021 (US$ Million) & (K Units)

Table 56. Middle East and Africa Advanced Parenteral Drug Delivery Devices Market Size, 2019-2021 (US$ Million) & (K Units)

Table 57. Abbott Laboratories Business Overview

Table 58. Abbott Laboratories Advanced Parenteral Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Abbott Laboratories Advanced Parenteral Drug Delivery Devices Product

Table 60. Abbott Laboratories Response to COVID-19 and Related Developments

Table 61. Amgen Business Overview

Table 62. Amgen Advanced Parenteral Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Amgen Advanced Parenteral Drug Delivery Devices Product

Table 64. Amgen Response to COVID-19 and Related Developments

Table 65. Pfizer Business Overview

Table 66. Pfizer Advanced Parenteral Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Pfizer Advanced Parenteral Drug Delivery Devices Product

Table 68. Pfizer Response to COVID-19 and Related Developments

Table 69. Roche Business Overview

Table 70. Roche Advanced Parenteral Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Roche Advanced Parenteral Drug Delivery Devices Product

Table 72. Roche Response to COVID-19 and Related Developments

Table 73. AstraZeneca Business Overview

Table 74. AstraZeneca Advanced Parenteral Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. AstraZeneca Advanced Parenteral Drug Delivery Devices Product

Table 76. AstraZeneca Response to COVID-19 and Related Developments

Table 77. BD Business Overview

Table 78. BD Advanced Parenteral Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. BD Advanced Parenteral Drug Delivery Devices Product

Table 80. BD Response to COVID-19 and Related Developments

Table 81. Boston Scientific Business Overview

Table 82. Boston Scientific Advanced Parenteral Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Boston Scientific Advanced Parenteral Drug Delivery Devices Product

Table 84. Boston Scientific Response to COVID-19 and Related Developments

Table 85. Bristol-Myers Squibb Business Overview

Table 86. Bristol-Myers Squibb Advanced Parenteral Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Bristol-Myers Squibb Advanced Parenteral Drug Delivery Devices Product

Table 88. Bristol-Myers Squibb Response to COVID-19 and Related Developments

Table 89. GSK Business Overview

Table 90. GSK Advanced Parenteral Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. GSK Advanced Parenteral Drug Delivery Devices Product

Table 92. GSK Response to COVID-19 and Related Developments

Table 93. Novartis Business Overview

Table 94. Novartis Advanced Parenteral Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Novartis Advanced Parenteral Drug Delivery Devices Product

Table 96. Novartis Response to COVID-19 and Related Developments

Table 97. Advanced Parenteral Drug Delivery Devices Distributors List

Table 98. Advanced Parenteral Drug Delivery Devices Customers List

Table 99. Covid-19 Impact on Advanced Parenteral Drug Delivery Devices Customers

List of Figures

Figure 1. Advanced Parenteral Drug Delivery Devices Product Picture

Figure 2. Advanced Parenteral Drug Delivery Devices Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Advanced Parenteral Drug Delivery Devices Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Advanced Parenteral Drug Delivery Devices Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Advanced Parenteral Drug Delivery Devices Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Advanced Parenteral Drug Delivery Devices Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Advanced Parenteral Drug Delivery Devices Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Advanced Parenteral Drug Delivery Devices Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Advanced Parenteral Drug Delivery Devices Market Size Market Share, 2019-2021

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450